Energy Modified Materials TRIZ Cases

Genetic profiling guides HDAC inhibitors and other targeted agents in canine cancers to improve efficacy while limiting ineffective treatment exposure.

Multi-stage flow separation, reorientation, and recombination improve light exposure for pathogen inactivation while preserving fluid components.

Magnetic field modulation switches bacterial motion modes to preserve motility and improve delivery to hypoxic zones with lower dosage and toxicity.

Laser-activated viral capsid conjugates target bladder tumors while checkpoint inhibitors boost durable anti-tumor immunity with less harm to normal cells.

Nanoparticle photothermal heating enables selective tumor ablation, while a cooled laser probe assembly helps prevent catheter char, deformation, and kinking.

A radiolabeled BF3-BPA boron carrier enables PET tracking of true in vivo distribution while supporting BNCT with the same chemical structure.

Photosensitizer plus UVA treatment of blood samples generates regulatory NK cells to prevent irAEs without blunting checkpoint anti-cancer activity.

Removing oxygen before riboflavin UV treatment helps inactivate pathogens while limiting hemolysis and microparticle formation during blood storage.

Near-infrared activated antibody conjugates selectively deplete pathogenic resident memory T cells in inflamed tissues while avoiding systemic immunosuppression.

Needleless injection uses shear stress to damage cancer cells and release DAMPs, activating cellular immunity without adjuvants.